(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Letter Sequence Other |
|---|
|
|
MONTHYEARML19311C6912019-12-10010 December 2019
Request for Withholding Information from Public Disclosure in October 31, 2019, Request for Review and Approval of ANP-10344P, Revision 0, Framatome Best-Estimate Enhanced Option III Methodology
Project stage: Withholding Request Acceptance
ML21025A4132021-02-16016 February 2021
Letter - Draft Safety Evaluation for Framatome Topical Report ANP-10344P, Revision 0, Framatome Best-Estimate Enhanced Option III Methodology
Project stage: Draft Approval
ML21084A0642021-03-12012 March 2021
Affidavit of Alan B. Meginnis
Project stage: Other
ML21084A0672021-03-15015 March 2021
Enclosures 3 and 4 - Summary of Proprietary Markings and Minor Clarifications for Draft SE of ANP-10344P, Revision 0, Framatome Best-Estimate Enhanced Option III Methodology, and Mark-up of Draft Safety Evaluation (Non-Proprietary)
Project stage: Draft Other
ML21084A0652021-03-15015 March 2021
Response to Request for Comment on Draft Safety Evaluation for ANP-10344P, Revision 0, Framatome Best-estimate Enhanced Option Ill Methodology
Project stage: Draft Request
ML21081A0042021-03-30030 March 2021
Final Safety Evaluation Letter for Framatome Topical Report ANP-10344P, Revision 0, Framatome Best-Estimate Enhanced Option III Methodology
Project stage: Approval
ML21141A0732021-05-21021 May 2021
Withholding Determination for Publication of ANP-10344P-A, Rev. 0, Framatome Best-Estimate Enhanced Option III Methodology (EPID L-2019-TOP-0046) (Transmittal E-mail)
Project stage: Other
ML21141A0752021-05-21021 May 2021
Withholding Determination for Publication of ANP-10344P-A, Rev. 0, Framatome Best-Estimate Enhanced Option III Methodology NRC 897
Project stage: Other
ML21144A0302021-06-0202 June 2021
Verification for Publication of Topical Report, ANP-10344P-A, Revision 0, Framatome Best-Estimate Enhanced Option III Methodology
Project stage: Other
ML21144A0642021-06-0202 June 2021
Verification for Publication of ANP-10344P-A - Framatome BEO-III - NRC 896
Project stage: Other
2021-03-15
[Table View] |
Text
From:
Otto, Ngola To:
PETERS Gary (Framatome)
Cc:
Morey, Dennis; ELLIOTT Gayle (Framatome); MEGINNIS Alan (Framatome)
Subject:
Withholding Determination for Publication of ANP-10344P-A, Rev. 0, Framatome Best-Estimate Enhanced Option III Methodology (EPID L-2019-TOP-0046)
Date:
Friday, May 21, 2021 12:16:00 PM Attachments:
Withholding Detmination for Publication of Framatome TR ANP-10344P-A BEO-III - NRC 897.pdf Mr. Gary Peters, Director Licensing and Regulatory Affairs Framatome, Inc.
3315 Old Forest Road Lynchburg, VA 24501
Mr. Peters,
Attached please find the completed NRC form 897 for the U.S. Nuclear Regulatory Commission staff forms for proprietary information withholding determination regarding Publication of Framatome Inc. (Framatome) topical report, ANP-10344P-A, Rev. 0, "Framatome Best-Estimate Enhanced Option III Methodology."
If you have any questions, please feel free to contact me.
Ngola Otto Project Manager, Licensing Projects Branch Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation US Nuclear Regulatory Commission e-mail: Ngola.Otto@nrc.gov phone: (301) 415-6695